DEF 14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:


☐		Preliminary Proxy Sta tement

☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒		Definitive Proxy Statement

☐		Definitive Additional Materials

☐		Soliciting Material under Rule 14a-12

STEPAN COMPANY

(Name of registrant as specified in its charter)

(Name of person(s) filing proxy statement, if other than the registrant)

Payment of Filing Fee (Check the appropriate box):



☒		No fee required.

☐		Fee paid previously with preliminary materials.

☐		Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

LOGO

2023 Proxy Statement and

Notice of Annual Meeting of Stockholders

STEPAN COMPANY

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To be held on April 25, 2023

at 9:00 a.m. (CDT)

To the Stockholders:

Notice is hereby given that the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) of Stepan Company (the “Company”) will be held at the Company’s offices at 1101 Skokie Boulevard, Northbrook, Illinois 60062, on Tuesday, April 25, 2023, at 9:00 a.m. (CDT), for the following purposes:

To elect two directors to the Board of Directors, each for a three-year term;

To approve, on an advisory basis, the compensation of the Company’s named executive officers (the “Say-on-Pay” vote);

To vote, on an advisory basis, on the frequency of voting on the compensation of the Company’s named executive officers (the “Say-on-Frequency” vote);

To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2023; and

To transact such other business as may properly come before the meeting.

The Board of Directors has designated the close of business on March 3, 2023, as the record date for determining the holders of record of the Company’s Common Stock entitled to notice of and to vote at the meeting.

The Board of Directors extends a cordial invitation to all stockholders to attend the Annual Meeting. Whether or not you plan to attend the meeting, please mark, sign and mail the enclosed proxy card in the return envelope provided or vote by internet or phone as promptly as possible.

As a reminder, your broker may not vote your shares for non-routine matters such as the election of directors, the Say-on-Pay vote or the Say-on-Frequency vote without your specific instructions as to how to vote. Therefore, we urge you to provide your broker with voting instructions by returning your proxy card so your votes for all proposals can be counted.

Directions to the Annual Meeting are available at https://stepan.gcs-web.com/annual-meeting for those stockholders who plan to attend the Annual Meeting.

By order of the Board of Directors,

DAVID G. KABBES

Secretary

Northbrook, Illinois

March 20, 2023

Important Notice Regarding the Availability of Proxy Materials for the

Annual Meeting of Stockholders to Be Held on April 25, 2023

The Company’s Proxy Statement, 2022 Annual Report to Stockholders and Annual Report on Form 10-K for the year ended December 31, 2022, are available at http://www.edocumentview.com/SCL.

TABLE OF CONTENTS



Information Concerning Solicitation and Voting			1

Proposal No. 1: Election of Directors			3

Nominees for Director			3

Continuing Directors Whose Terms Are Not Expiring			5

Security Ownership			8

Security Ownership of Certain Beneficial Owners			8

Security Ownership of the Board of Directors and Management			8

Equity Compensation Plan Information			11

Certain Relationships and Related Party Transactions			12

Policies and Procedures for Approving Related Person Transactions			12

Transactions with Related Persons, Promoters and Certain Control Persons			12

Corporate Governance Principles and Board Matters			13

Corporate Governance Guidelines and Code of Conduct			13

Board Committees			13

Board Performance Evaluations			14

Board Meetings and Attendance			15

Director Nomination Process			15

Board Diversity			16

Director Independence			16

Board Leadership Structure			17

Risk Management			18

Executive Sessions			18

Compensation Committee Interlocks and Insider Participation			19

Executive Compensation			20

Compensation Discussion and Analysis			20

Summary of Executive Compensation in 2022			20

Significant Achievements and Developments in 2022			20

Executive Compensation Best Practices the Company Follows			21

Compensation Philosophy			21

Compensation Objectives			22

Role of the Human Capital and Compensation Committee			22

Role of the Compensation Consultant			22

Role of the Committee and Executives in Establishing Executive Compensation			23

Advisory Vote on Executive Compensation			23

Executive Pay Mix			24

Compensation Peer Group and Survey Data			24



Elements of Compensation			25

Clawback Policy			34

Stock Ownership Policy			34

Hedging and Trading Restrictions			35

Post-Termination Benefits			35

Impact of Tax and Accounting Considerations			35

Human Capital and Compensation Committee Report			36

Executive Compensation Tables			37

2022 Summary Compensation Table			37

2022 Grants of Plan-Based Awards			39

Outstanding Equity Awards at 2022 Fiscal Year-End			41

2022 Option Exercises and Stock Vested			43

2022 Pension Benefits			44

2022 Nonqualified Deferred Compensation			46

Potential Payments upon Termination or Change in Control			47

CEO Pay Ratio			48

Pay Versus Performance			49

Director Compensation			52

Overview of Director Compensation Program			52

Directors’ Fees			52

Directors Deferred Compensation Plan			52

Stock Awards and Incentive Compensation Program for Non-Employee Directors			52

Non-Employee Directors’ Stock Ownership Policy			53

Hedging and Trading Restrictions			53

2022 Director Compensation Table			53

Proposal No. 2: Advisory Vote to Approve Named Executive Officer Compensation			54

Proposal No. 3: Advisory Vote on the Frequency of Future Say-on-Pay Votes			56

Audit Committee Report			57

Proposal No. 4: Ratify the Appointment of Deloitte & Touche LLP as the Company’s Independent Public Accounting Firm for 2023			58

Independent Registered Public Accounting Firm Fees			58

Pre-Approval Policy			59

2024 Stockholder Proposals and Director Nominations			60

Communications for All Interested Parties			60

Annual Report to Stockholders			61

Appendix A: Explanations of GAAP and Non-GAAP Financial Measures			A-1

March 20, 2023

PROXY STATEMENT

For the Annual Meeting of Stockholders of

STEPAN COMPANY

1101 Skokie Boulevard

Northbrook, Illinois 60062

To be held at 9:00 a.m. (CDT) on April 25, 2023

INFORMATION CONCERNING SOLICITATION AND VOTING

The enclosed proxy is solicited by the Board of Directors, and the Company will bear the entire expense of solicitation. Such solicitation is being made by mail, and the Company’s officers and employees may solicit proxies from stockholders personally or by telephone, mail or other means. The Company will make arrangements with the brokers, custodians, nominees and other fiduciaries who request the forwarding of solicitation material to the beneficial owners of shares of the Company’s stock held of record by such brokers, custodians, nominees and other fiduciaries, and the Company will reimburse them for their reasonable out-of-pocket expenses. This proxy statement and proxy are first being distributed to stockholders commencing on or about March 20, 2023.

At the close of business on March 3, 2023, the record date for the meeting, there were 22,306,611 shares of the Company’s Common Stock (“Common Stock”) outstanding, each share of which is entitled to one vote on each matter to be voted on at the meeting. The required quorum at the Annual Meeting is a majority of the outstanding shares of the Company’s Common Stock as of the record date.

If you submit your proxy but abstain from voting on one or more matters, your shares will be counted as present at the meeting for the purposes of determining a quorum. You may revoke your proxy by attending the meeting and voting in person or by delivering to the Secretary of the Company a revocation of the proxy or an executed new proxy bearing a later date.

You may vote “FOR,” “AGAINST” or “ABSTAIN” on each of the nominees for the Board of Directors. You may vote “ONE YEAR,” “TWO YEARS,” “THREE YEARS” or “ABSTAIN” on the Say-on-Frequency vote. You may vote “FOR,” “AGAINST” or “ABSTAIN” on each of the other proposals. If you vote to “ABSTAIN” with respect to a nominee for the Board of Directors, your abstention will not be included in the vote totals and will not affect the outcome of the vote. If you vote to “ABSTAIN” with respect to any proposal other than the Say-on-Frequency vote, your abstention will have the effect of a vote against the proposal.

For any other business that may properly come before the meeting, votes will be cast pursuant to the authority granted by the enclosed proxy in accordance with the best judgment of the individuals acting under the proxy. The Board of Directors is not currently aware of any other business that may come before the meeting.

If you hold your shares in street name and do not provide voting instructions to your broker, custodian, nominee or other fiduciary, your shares will not be voted on any non-routine matters and will be considered “broker non-votes.” Non-routine matters include the election of directors, the Say-on-Pay vote and the Say-on-Frequency vote. Your broker may vote your shares without instruction on the ratification of the appointment of the Company’s independent registered public accounting firm. Broker

non-votes will be counted as present at the meeting for the purpose of determining a quorum but will not be included in the vote totals for non-routine matters and will not affect the outcome of those votes. Please instruct your broker or bank so your vote can be counted on all proposals.

In order to ensure the necessary quorum at the Annual Meeting, please mark, sign and return the enclosed proxy promptly in the envelope provided. You may also vote via the internet by visiting http://www.envisionreports.com/SCL or by phone by calling (800) 652-8683. Internet and phone voting will be available 24 hours a day, seven days a week until 1:00 a.m. (EDT) on April 25, 2023. If voting via the internet or by phone, please have your proxy card available and follow the instructions to vote. Even if you vote prior to the meeting, you are invited to attend the meeting.

In the future, in accordance with the rules of the Securities and Exchange Commission (the “SEC”), the Company may furnish proxy materials, including its proxy statements and annual reports, to stockholders by providing access to these documents on the internet instead of mailing printed copies. If the Company elects to take this approach, most stockholders would not receive printed copies of the proxy materials. Instead, the notice would provide instructions on how to access and review the proxy materials on the internet. The notice would also provide instructions on how to submit your proxy via the internet. For stockholders who prefer to receive printed copies of the proxy materials, the notice would provide instructions for requesting printed copies.

PROPOSAL NO. 1: ELECTION OF DIRECTORS

Stockholders and the persons named in the enclosed proxy will vote, pursuant to the authority granted by the stockholder in the enclosed proxy, on the election of Dr. Joaquin Delgado and Mr. F. Quinn Stepan, Jr. as directors of the Company, to hold office until the Annual Meeting of Stockholders to be held in 2026. The Board of Directors is divided into three classes serving staggered three-year terms. Directors for each class are elected at the annual meeting of stockholders in the year in which the term for their class expires. Dr. Delgado and Mr. Stepan are current directors whose terms expire in 2023. Dr. Delgado and Mr. Stepan were last elected by the Company’s stockholders at the 2020 Annual Meeting. The nominations of Dr. Delgado and Mr. Stepan have each been reviewed and recommended by the Nominating and Corporate Governance Committee and the Board of Directors.

In the event any of Dr. Delgado or Mr. Stepan is unable to serve as director, votes will be cast, pursuant to the authority granted in the proxy, for such person or persons as may be designated by the Board of Directors. The Board of Directors at this time is not aware of any nominee who is or will be unable to serve as director, if elected.

Under the Company’s Amended and Restated By-laws, in an uncontested election directors are elected by a majority of the votes cast by stockholders. An uncontested election of directors means an election for which the number of nominees does not exceed the number of directors to be elected at the specific election. Because two directors are to be elected, and Dr. Delgado and Mr. Stepan are the sole nominees, this election is uncontested, and therefore the nominees must receive a majority of votes cast by stockholders to be elected.

Nominees for Director

The following table sets forth certain information about the nominees for director:

Joaquin Delgado

LOGO

Age: 63

Director Since: 2011

Experience

Executive Vice President, Consumer Business Group of 3M Company, a global diversified technology company, from July 2016 to July 2019. Executive Vice President, Health Care Business Group of 3M Company, from October 2012 to July 2016. Trustee of Goldman Sachs Asset Management, L.P. and Trustee of two registered investment companies managed by Goldman Sachs Asset Management, L.P.

Qualifications

Dr. Delgado also held other executive leadership positions at 3M Company and holds a doctorate in polymer science and engineering. Dr. Delgado provides the Board of Directors with chemistry and innovation expertise and global business, operational, manufacturing, marketing and corporate development experience.


F. Quinn Stepan, Jr.
Age: 62 Director Since: 1999		Experience Chairman of the Company since January 2017. Chief Executive Officer of the Company from January 2006 through April 2022. President of the Company from January 2006 through December 2020. Qualifications In his over 30-year career with the Company, Mr. Stepan served in a number of positions of increasing responsibility and in a variety of functions within the Company’s operations. Mr. Stepan’s leadership provides the Board of Directors with extensive knowledge of the Company’s strategy and operations.

PROPOSAL: The Board of Directors recommends that the stockholders vote FOR the election of Dr. Delgado and Mr. Stepan to the Board of Directors, each for a three-year term.

Continuing Directors Whose Terms Are Not Expiring

The following table sets forth certain information about those directors who are not up for election:


Scott R. Behrens
Age: 53 Director Since: 2022 Term Expires: 2025		Experience President and Chief Executive Officer of the Company since April 2022. President and Chief Operating Officer of the Company from January 2021 through April 2022. Vice President and General Manager – Surfactants of the Company from September 2014 through December 2020. Qualifications Mr. Behrens has served the Company for 30 years, including as general manager of the Company’s largest business segment, Surfactants. The Board believes that Mr. Behrens provides key insight into the Company’s day to-day operations.

Lorinda A. Burgess
Age: 60 Director Since: 2021 Term Expires: 2025		Experience Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc., a medical technology company, since March 2015. Qualifications Ms. Burgess provides the Board of Directors with financial expertise and with broad operational and strategic experience developed throughout her career in a range of financial leadership roles.


Randall S. Dearth
Age: 59 Director Since: 2012 Term Expires: 2024		Experience Senior Director of SK Capital Partners, LP, a private investment firm, since January 2021. President and Chief Executive Officer of GCP Applied Technologies Inc., a leading global provider of construction products technologies, from August 2019 to September 2020. President and Chief Operating Officer of GCP Applied Technologies Inc. from September 2018 to July 2019. Chairman of Calgon Carbon Corporation, a global manufacturer of activated carbon and innovative treatment systems, from May 2014 to March 2018. President and Chief Executive Officer of Calgon Carbon Corporation from August 2012 to August 2018. Qualifications Mr. Dearth also previously served as the President and Chief Executive Officer of LANXESS Corporation, a global chemicals manufacturer. Mr. Dearth provides the Board of Directors with global executive leadership in the chemical industry and a global perspective on strategy and business conditions.

Gregory E. Lawton
		Experience Consultant. President and Chief Executive Officer of JohnsonDiversey, Inc., a leading global provider of cleaning and hygiene solutions to the institutional and industrial marketplace, from October 2000 to February 2006. Director of General Cable Corporation from 1997 to 2018. Qualifications Mr. Lawton previously held various leadership roles at other companies and is a director of American Trim, LLC. Mr. Lawton provides the Board of Directors with global expertise and executive leadership from the consumer products industry, and extensive experience with employee development.
Age: 72 Director Since: 2006 Term Expires: 2024
Jan Stern Reed
Age: 63 Director Since: 2015 Term Expires: 2024		Experience Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance, Inc., a global pharmacy-led, health and wellbeing enterprise, from February 2015 to February 2016. Senior Vice President, General Counsel and Secretary of Walgreen Co. from October 2014 to February 2015. Director of AngioDynamics, Inc. (ANGO) and Avita Medical, Inc. (RCEL). Qualifications Prior to joining Walgreens, Ms. Reed was the Executive Vice President of Human Resources, General Counsel and Secretary of Solo Cup Company. Ms. Reed provides the Board of Directors with global executive leadership experience in legal, corporate governance and strategic business matters, as well as extensive experience with risk management, compliance, acquisitions and employee development.

Edward J. Wehmer

LOGO

Age: 69

Director Since: 2003

Term Expires: 2025

Experience

Founder and Chief Executive Officer of Wintrust Financial Corporation, a financial services company, since February 2020. President and Chief Executive Officer of Wintrust Financial Corporation from May 1998 to February 2020. Director of Wintrust Financial Corporation (WTFC).

Qualifications

Mr. Wehmer is also a Certified Public Accountant. Mr. Wehmer provides the Board of Directors with expertise in strategic, financial, banking and accounting matters. Mr. Wehmer also has extensive experience with acquisitions.

SECURITY OWNERSHIP

Security Ownership of Certain Beneficial Owners

As of March 3, 2023, the following persons were the only persons known to the Company to beneficially own more than five percent of the Company’s Common Stock, other than members of the Company’s Board of Directors or management, whose ownership is set forth in the table below:


Name and Address	Number of Shares of Common Stock Beneficially Owned		Percentage of Outstanding Shares of Common Stock (1)

BlackRock, Inc. (2)		3,678,414		16.5%
The Vanguard Group, Inc. (3)		2,557,418		11.5%
State Street Corporation (4)		1,856,574		8.3%
SSGA Funds Management, Inc. (4)		1,221,007		5.5%

(1)	Based on 22,306,611 shares of Common Stock outstanding as of March 3, 2023.

(2)

As reported in a Schedule 13G/A filed with the SEC on January 23, 2023, by BlackRock, Inc. (“BlackRock”), 55 East 52nd Street, New York, New York 10055. In the Schedule 13G/A, BlackRock reported that, as of December 31, 2022, it had sole voting power as to 3,598,359 shares of Common Stock and sole dispositive power as to 3,678,414 shares of Common Stock.

(3)

As reported in a Schedule 13G/A filed with the SEC on February 9, 2023, by The Vanguard Group (“Vanguard”), 100 Vanguard Boulevard, Malvern, Pennsylvania 19355. In the Schedule 13G/A, Vanguard reported that, as of December 31, 2022, it had shared voting power as to 17,389 shares of Common Stock, sole dispositive power as to 2,518,588 shares of Common Stock, and shared dispositive power as to 38,830 shares of Common Stock.

(4)

As reported in a Schedule 13G/A filed with the SEC on February 10, 2023, by State Street Corporation (“State Street”) and SSGA Funds Management, Inc. (“SSGA”), State Street Financial Center, 1 Lincoln Street, Boston, Massachusetts 02111. In the Schedule 13G/A, (a) State Street reported that, as of December 31, 2022, it had shared voting power as to 1,799,146 shares of Common Stock and shared dispositive power as to 1,856,574 shares of Common Stock, and (b) SSGA reported that, as of December 31, 2022, it had shared voting power as to 1,216,182 shares of Common Stock and shared dispositive power as to 1,221,007 shares of Common Stock.

Security Ownership of the Board of Directors and Management

The following table sets forth, as of March 3, 2023, the security ownership of each executive officer listed in the Summary Compensation Table in this proxy statement, each director and nominee for director, and all currently serving directors and executive officers as a group. The address for each

director, nominee for director, and executive officer is c/o Stepan Company, 1101 Skokie Boulevard, Northbrook, Illinois 60062.


Name	Number of Shares of Common Stock Beneficially Owned (1)		Percentage of Outstanding Shares of Common Stock (1)

Scott R. Behrens		50,700 (2)		*
Lorinda A. Burgess		2,009		*
Randall S. Dearth		10,762 (3)		*
Joaquin Delgado		10,850		*
David G. Kabbes		16,222 (4)		*
Gregory E. Lawton		21,583 (5)		*
Arthur W. Mergner		66,601 (6)		*
Sean T. Moriarty		31,527 (7)		*
Jan Stern Reed		8,690		*
Luis E. Rojo		24,104 (8)		*
F. Quinn Stepan, Jr.		880,130 (9)		3.9%
Edward J. Wehmer		24,526 (10)		*
All Directors and Executive Officers		1,545,995 (11)		6.9%

*	Less than one percent of outstanding shares of Common Stock.

(1)

Based on 22,306,611 shares of Common Stock outstanding as of March 3, 2023. Number of shares of Common Stock for each director, nominee for director, and executive officer (and all directors and executive officers as a group) includes (a) shares of Common Stock owned by the spouse of each director, nominee for director, or executive officer, and shares of Common Stock held by each director, nominee for director, or executive officer, or such person’s spouse as trustee or custodian for the benefit of children and family members if such trustee or custodian has voting or investment power, (b) shares of Common Stock that may be acquired within 60 days through the exercise of stock options or stock appreciation rights (“SARs”) granted pursuant to the Company’s incentive compensation plans, and (c) shares of Common Stock pledged as security by such director, nominee for director, or executive officer, or such person’s family members.

(2)

Includes (a) 4,087 shares of Common Stock allocated to Mr. Behrens under the Company’s Employee Stock Ownership Plan II (“ESOP II”), (b) 16,199 shares of Common Stock that Mr. Behrens has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, (c) 1,668 shares of Common Stock that Mr. Behrens has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans, and (d) 14,031 shares of Common Stock credited to Mr. Behrens’ stock account under the Management Incentive Plan (as amended and restated effective January 1, 2015, the “Management Incentive Plan”). Amounts credited to an employee’s stock account will be paid to the employee at the time of separation of service from the Company as the employee has elected under the provisions of the Management Incentive Plan.

(3)	Includes 1,287 shares of Common Stock credited to Mr. Dearth’s account pursuant to the Stepan Company Directors Deferred Compensation Plan (as amended and restated as of January 1, 2012).

(4)

Includes (a) 298 shares of Common Stock allocated to Mr. Kabbes under ESOP II, (b) 7,282 shares of Common Stock that Mr. Kabbes has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, and (c) 1,381 shares of Common Stock that Mr. Kabbes has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans.

(5)	Includes 5,869 shares of Common Stock credited to Mr. Lawton’s account pursuant to the Company’s incentive compensation plans.

(6)

Includes (a) 178 shares of Common Stock allocated to Mr. Mergner under ESOP II, (b) 19,395 shares of Common Stock that Mr. Mergner has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, (c) 11,009 shares of Common Stock that Mr. Mergner has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans, and (d) 8,593 shares of Common Stock credited to Mr. Mergner’s stock account under the Management Incentive Plan.

(7)

Includes (a) 4,234 shares of Common Stock allocated to Mr. Moriarty under ESOP II, (b) 8,533 shares of Common Stock that Mr. Moriarty has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, (c) 2,738 shares of Common Stock that Mr. Moriarty has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans, and (d) 5,542 shares of Common Stock credited to Mr. Moriarty’s stock account under the Management Incentive Plan.

(8)

Includes (a) 405 shares of Common Stock allocated to Mr. Rojo under ESOP II, (b) 10,936 shares of Common Stock that Mr. Rojo has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, (c) 3,397 shares of Common Stock that Mr. Rojo has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans, and (d) 2,261 shares of Common Stock credited to Mr. Rojo’s account under the Management Incentive Plan.

(9)

Includes (a) 90 shares of Common Stock allocated to Mr. Stepan under ESOP II, (b) 207,318 shares of Common Stock that Mr. Stepan has the right to acquire through the exercise of stock options granted pursuant to the Company’s incentive compensation plans, (c) 19,630 shares of Common Stock that Mr. Stepan has the right to acquire through the exercise of SARs granted pursuant to the Company’s incentive compensation plans, and (d) 90,597 shares of Common Stock credited to Mr. Stepan’s stock account under the Management Incentive Plan.

(10)	Includes 13,824 shares of Common Stock credited to Mr. Wehmer’s account pursuant to the Company’s incentive compensation plans.

(11)

As of March 3, 2023, directors and executive officers as a group had (a) 11,055 shares of Common Stock allocated to them under ESOP II, (b) the right to acquire 280,036 shares of Common Stock through the exercise of stock options, (c) the right to acquire 41,322 shares of Common Stock through the exercise of SARs, and (d) 123,674 shares of Common Stock credited to their stock accounts under the Management Incentive Plan. In addition, the amount shown includes 130,257 shares of Common Stock that were held in the Company’s qualified plans and deemed to be beneficially owned by the Plan Committee, which is comprised of executive officers of the Company. The Plan Committee selects the investment manager of the Stepan Company Trust for Qualified Plans under the terms of a Trust Agreement effective December 1, 2011, with Bank of America, N.A. (“Bank of America”). Bank of America expressly disclaims any beneficial ownership in the securities of this plan.

Equity Compensation Plan Information

The following table provides information as of December 31, 2022, about the Company’s securities that may be issued under the Company’s existing equity compensation plans, all of which have been approved by the stockholders:


Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights	Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

	(a)	(b)	(c)
Equity compensation plans approved by security holders	1,364,643 (1)	$ 90.86 (2)	810,080
Equity compensation plans not approved by security holders	—	—	—

Total	1,364,643	$ 90.86	810,080

(1)	Includes unvested performance share awards, with the number of performance shares based on the probable number of shares that will ultimately vest given the projected level of performance.

(2)	Excludes unvested performance share awards.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Policies and Procedures for Approving Related Person Transactions

The Company has adopted a written policy entitled “Stepan Company Related Party Transaction Policy and Procedures.” The policy was initially approved by the Audit Committee of the Board of Directors in February 2007, has been annually reviewed by the Audit Committee and was last amended in April 2021 (“Related Party Transaction Policy”). This policy applies to material transactions (“Related Party Transactions”) involving the Company and a Related Party, which is defined as a person or entity who is a Company executive officer, director, nominee for election as a director, beneficial owner of five percent or more of the Company’s Common Stock, or immediate family member of these persons, or any entity for which any of the foregoing persons is an executive officer, general partner, managing member, principal or greater than five percent beneficial owner. The Related Party Transaction Policy states that the Company will consummate a Related Party Transaction only when the Audit Committee approves the transaction after considering the factors set forth in the Related Party Transaction Policy. If advance Audit Committee approval of a Related Party Transaction is not feasible, then the Company may preliminarily enter into the transaction upon prior approval by the Chair of the Audit Committee, subject to ratification of the transaction by the Audit Committee at its next regularly scheduled meeting. No director may participate in the approval of a Related Party Transaction for which he or she is a Related Party.

The factors considered by the Audit Committee in its evaluation of a Related Party Transaction include the relevant facts and circumstances of the proposed Related Party Transaction, whether the Related Party Transaction is on terms comparable to those that could be obtained in arm’s-length dealings with an unrelated third party, the extent of the related party’s interest in the transaction and the conflicts of interest and corporate opportunity provisions of the Company’s Code of Conduct.

Transactions with Related Persons, Promoters and Certain Control Persons

Mr. Richard Stepan, brother of F. Quinn Stepan, Jr., Chairman of the Board, is a current officer of the Company. Mr. Richard Stepan is neither a director nor a nominee for director. As an employee of the Company, Mr. Richard Stepan receives a base salary, short-term and long-term incentive compensation as appropriate for his position and other regular and customary employee benefits generally available to all Company employees, and is eligible for other limited perquisites available to employees at his level within the organization. For 2022, Mr. Richard Stepan was paid a salary of $315,000, short-term incentive compensation of $347,235 and a long-term incentive compensation award of SARs and performance shares with a target value of $450,000. The Audit Committee approved the Company’s employment of Mr. Richard Stepan pursuant to the Related Party Transaction Policy and procedures described above.

CORPORATE GOVERNANCE PRINCIPLES AND BOARD MATTERS

Corporate Governance Guidelines and Code of Conduct

The Company is committed to having sound corporate governance principles and has adopted Corporate Governance Guidelines and a Code of Conduct to maintain those principles. The Company’s Code of Conduct applies to all of the Company’s directors, officers and employees, including the Company’s Chief Executive Officer and Chief Financial Officer. The Company’s Corporate Governance Guidelines and Code of Conduct are available at https://stepan.gcs-web.com/corporate-governance/highlights. Stockholders may also request free printed copies of the Company’s Corporate Governance Guidelines and Code of Conduct by contacting the Company’s Secretary at Stepan Company, Secretary’s Office, 1101 Skokie Boulevard, Northbrook, Illinois 60062.

Board Committees

The Board of Directors has four standing committees: the Audit Committee, the Compliance Committee, the Human Capital and Compensation Committee, and the Nominating and Corporate Governance Committee, each composed entirely of independent directors. The charter of each committee is available at https://stepan.gcs-web.com/corporate-governance/highlights.

Audit Committee

The primary functions of the Audit Committee are to (a) assist the Board of Directors in fulfilling its oversight responsibilities to stockholders, the investment community and creditors in relation to (i) the quality and integrity of the Company’s financial statements, (ii) the adequacy of the Company’s internal control over financial reporting, (iii) the Company’s compliance with legal and regulatory requirements (in coordination with the Compliance Committee), (iv) the registered public accounting firm’s qualifications and independence, and (v) the performance of the independent auditors and the Company’s internal audit function; and (b) prepare the Audit Committee report included in each proxy statement. The responsibilities of the Audit Committee include annual selection and engagement of the Company’s independent registered public accounting firm, review of the proposed fees and scope of work of the independent registered public accounting firm’s year-end audit, review with the Company’s independent registered public accounting firm of the results of the year-end audits of the Company’s financial statements and internal control over financial reporting, review of the Company’s financial statements with the Company’s independent registered public accounting firm prior to the Company’s filing of each quarterly report on Form 10-Q and annual report on Form 10-K, review of findings reported by the Company’s internal audit department and management’s responses, review of the internal audit program of the Company and review, approval or disapproval of Related Party Transactions pursuant to the Company’s Related Party Transaction Policy and review of the Company’s risk assessment and risk management policies and procedures, including those relating to the Company’s enterprise risks, financial risks and information security risks. The Audit Committee held four meetings in 2022.

The Audit Committee is comprised of Ms. Burgess (Chair), Mr. Dearth, Dr. Delgado, Mr. Lawton, Ms. Reed and Mr. Wehmer, all of whom are financially literate and are independent directors in accordance with the rules of the New York Stock Exchange and the SEC and as described below under “Director Independence.” The Board of Directors has determined that each of Ms. Burgess and Mr. Wehmer qualifies as an audit committee financial expert within the meaning of SEC regulations.

Compliance Committee

The primary functions of the Compliance Committee are to assist the Board in fulfilling its oversight responsibilities with respect to (a) the Company’s overall compliance with significant legal and

regulatory requirements, as well as (b) compliance with its business ethics policies and Code of Conduct. The Compliance Committee held four meetings in 2022.

The Compliance Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton, Ms. Reed (Chair) and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and as described below under “Director Independence.”

Human Capital and Compensation Committee

The Human Capital and Compensation Committee was called the Compensation and Development Committee until February 15, 2023. The primary functions of the Human Capital and Compensation Committee are to (a) establish and administer the Company’s policies, programs and procedures for compensating its executive management and (b) provide advice and counsel to the Company regarding executive development and succession planning. The responsibilities of the Human Capital and Compensation Committee include reviewing and setting or recommending the compensation of the Company’s executive officers, recommending and administering cash-based and equity-based incentive compensation plans, reviewing and recommending director compensation, reviewing and recommending the Company’s Compensation Discussion and Analysis included in each proxy statement, and preparing the Human Capital and Compensation Committee Report included in each proxy statement. The Human Capital and Compensation Committee also reviews and advises management regarding the Company’s human capital management, including culture, diverse representation, inclusion and pay equity strategies, programs and initiatives. The Human Capital and Compensation Committee held three meetings in 2022.

The Human Capital and Compensation Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton (Chair), Ms. Reed and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and the SEC and as described below under “Director Independence.”

Nominating and Corporate Governance Committee

The primary functions of the Nominating and Corporate Governance Committee are to (a) identify individuals qualified to become board members and recommend the director nominees for election at each annual meeting of stockholders, (b) develop and recommend the Company’s Corporate Governance Guidelines, (c) oversee the evaluation of the Board of Directors and (d) recommend the members for each Board committee. In addition, the responsibilities of the Nominating and Corporate Governance Committee include making recommendations to the Board on corporate governance matters and the Board’s structure. The Nominating and Corporate Governance Committee held three meetings in 2022.

The Nominating and Corporate Governance Committee is comprised of Ms. Burgess, Mr. Dearth, Dr. Delgado (Chair), Mr. Lawton, Ms. Reed and Mr. Wehmer, all of whom are independent directors in accordance with the rules of the New York Stock Exchange and as described below under “Director Independence.”

Board Performance Evaluations

Annually, each director completes an evaluation of the full Board of Directors and of each standing committee on which the director serves. The Company’s Vice President, General Counsel and Secretary compiles the results of the assessments and provides the results to the Nominating and Governance Committee and to the Board of Directors. The Board of Directors initially discusses the assessment results with the Chairman and the Chief Executive Officer in attendance, and if desired by

any director, the assessment results are also discussed at Executive Sessions of the non-management directors and at Executive Sessions of the independent directors. This assessment evaluates the Board of Directors’ composition and contribution as a whole to the Company and reviews areas in which the Board of Directors and/or management believes a stronger contribution could be made. The Nominating and Corporate Governance Committee is also responsible for evaluating the performance of current members of the Board of Directors at the time they are considered for re-nomination to the Board of Directors.

Board Meetings and Attendance

During 2022, the Board of Directors held five meetings. During 2022, all of the directors attended more than 75% of the total number of meetings of the Board of Directors and the meetings of committees of the Board of Directors of which each director was a member. While all directors are encouraged to attend, the Company does not have a formal policy requiring attendance at the Company’s annual meeting of stockholders. All directors attended the 2022 Annual Meeting of Stockholders in person or via remote communication. The Company currently expects that all directors and nominees will attend the 2023 Annual Meeting.

Director Nomination Process

The Corporate Governance Guidelines contain the Board of Directors membership criteria that apply to nominees recommended by the Nominating and Corporate Governance Committee for a position on the Board of Directors. Under these criteria, members of the Board of Directors should possess qualities that include strength of character, an inquiring and independent mind, practical wisdom and mature judgment. In addition to these qualities, director nominees should also possess recognized achievement, an ability to contribute to some aspect of the Company’s business, and the willingness to make the commitment of time and effort required of a director. The Nominating and Corporate Governance Committee’s process for identifying and evaluating director nominees includes recommendations by stockholders, non-management directors and executive officers, a review and background check of specific candidates, an assessment of the candidate’s independence under the director independence standards described below, and interviews of director candidates by the Nominating and Corporate Governance Committee.

It is the policy of the Nominating and Corporate Governance Committee to consider candidates recommended by stockholders for membership on the Board of Directors. The Nominating and Corporate Governance Committee’s evaluation of a nominee recommended by a stockholder would consider the general criteria and required information previously described in this section, and any other factors the Nominating and Corporate Governance Committee deems relevant. Any stockholder recommendation proposed for consideration by the Nominating and Corporate Governance Committee must comply with the requirements set forth in the Company’s By-laws. Among other things, a stockholder must give written notice containing the information required by the Company’s By-laws to the Secretary of the Company at Stepan Company, Secretary’s Office, 1101 Skokie Boulevard, Northbrook, Illinois 60062. The deadline to submit a director recommendation for the 2024 Annual Meeting of Stockholders is set forth in the “2024 Stockholder Proposals and Director Nominations” section below.

Board Diversity

The following charts summarize the current composition of the Board of Directors:

In accordance with the Company’s Corporate Governance Guidelines, when identifying director nominees, the Nominating and Corporate Governance Committee and the Board of Directors consider a broad definition of diversity. This definition includes, but is not limited to, diversity of professional, technical, operational, international and financial experience, skills and characteristics. In addition, the Nominating and Corporate Governance Committee and the Board will consider demographics such as age, race, ethnicity, gender and sexual orientation. The Board has also considered experience related to the Company’s business and industry. If the Nominating and Corporate Governance Committee utilizes an outside search firm to identify director nominees, it instructs the search firm to consider broadly-defined diversity in identifying potential nominees.

As the Company has grown, the composition of the Board has evolved. In addition to adding valuable expertise and experience, the Company’s five most recently appointed directors added diversity with respect to age, ethnicity and gender to the Board. For example, two of the Board’s most recently appointed directors, Jan Stern Reed, who is Chair of the Board’s Compliance Committee, and Lorinda Burgess, who is Chair of the Board’s Audit Committee, brought gender diversity to the Board. Ms. Burgess and Joaquin Delgado also added ethnic diversity to the Board. The Company sees tremendous value in having diversity of experience, skills, characteristics and demographics on the Board.

Director Independence

For purposes of determining director independence, the Company uses the New York Stock Exchange director independence standards. No director qualifies as “independent” unless the Board of Directors affirmatively determines that the director has no material relationship with the Company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the Company). In addition, a director is not independent if:

•

The director is, or has been within the last three years, an employee of the Company, or an immediate family member is, or has been within the last three years, an executive officer of the Company;

•

The director has received, or has an immediate family member who has received, during any 12-month period within the last three years, more than $120,000 in direct compensation from the Company, other than director and committee fees and pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service);

•

(A) The director is a current partner or employee of a firm that is the Company’s internal auditor or independent registered public accounting firm; (B) the director has an immediate

family member who is a current partner of such a firm; (C) the director has an immediate family member who is a current employee of such a firm and personally works on the Company’s audit; or (D) the director or an immediate family member was within the last three years a partner or employee of such a firm and personally worked on the Company’s audit within that time;

•

The director or an immediate family member is, or has been within the last three years, employed as an executive officer of another company where any of the Company’s present executive officers at the same time serves or served on that company’s compensation committee; or

•

The director is a current employee, or an immediate family member is a current executive officer, of a company that has made payments to, or received payments from, the Company for property or services in an amount which, in any of the last three fiscal years, exceeds the greater of $1 million or 2% of such other company’s consolidated gross revenues.

Under the New York Stock Exchange rules and the Company’s Corporate Governance Guidelines, at least a majority of the Company’s directors and each member of the Audit Committee, Compliance Committee, Human Capital and Compensation Committee and Nominating and Corporate Governance Committee must meet the independence standards set forth above. The Board of Directors has determined that each of Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton, Ms. Reed and Mr. Wehmer is independent under the standards set forth above. In addition, the Board of Directors has determined that each of the members of the standing committees satisfies the Company’s independence standards, including the additional independence standards and financial literacy requirements required for audit committee members and compensation committee members, as applicable, established by SEC and New York Stock Exchange rules. Mr. Stepan is not deemed independent under the rules of the New York Stock Exchange because he served as an employee of the Company until April 25, 2022. Mr. Behrens is not deemed independent under the rules of the New York Stock Exchange because he currently serves as the President and Chief Executive Officer of the Company.

In making independence determinations, the Nominating and Corporate Governance Committee, with assistance from the Company’s legal counsel, evaluated responses to a questionnaire completed annually by each director regarding relationships and possible conflicts of interest between each director, the Company and management. In its review of director independence, the Nominating and Corporate Governance Committee considered the commercial, industrial, banking, consulting, legal, accounting, charitable, and familial relationships any director may have with the Company or management. In addition, the Nominating and Corporate Governance Committee considered any relationships between the Company and entities for which any director serves as management or a member of the board of directors. The Nominating and Corporate Governance Committee recommended, and the Board of Directors approved, that the six directors named above be considered independent.

Board Leadership Structure

The Board of Directors regularly reviews its leadership structure in light of the Company’s then-current needs, trends, internal assessments of Board effectiveness, and other factors. The Board does not have a policy regarding the separation of the roles of Chief Executive Officer and Chairman of the Board because the Board believes it is in the best interests of the Company to make that determination based on the position and direction of the Company and the membership of the Board.

Currently, the Board believes the interests of the Company and its stockholders are best served through a leadership model with the roles of Chairman and Chief Executive Officer separated.

Mr. Stepan, who served as the Company’s Chief Executive Officer until April 25, 2022, continues to serve as Chairman of the Board. Mr. Behrens succeeded Mr. Stepan as Chief Executive Officer and is a member of the Board.

The Board believes that Mr. Stepan’s experience puts him in the best position to provide broad leadership for the Board as Chairman as the Board works to deliver value to stockholders. Mr. Stepan possesses extensive knowledge and understanding of the Company and its operations, strategic planning matters, and the industry in general, developed during his over 30-year career with the Company.

Because Mr. Stepan is not deemed independent, the Board has elected Mr. Wehmer as Lead Independent Director to aid the Board of Directors’ independent oversight of the Company and management. The Board believes that the election of the Lead Independent Director enhances the Board’s commitment to maintaining strong corporate governance and provides effective independent Board leadership. Among other responsibilities, the Lead Independent Director presides at all Executive Sessions of the independent directors, advises the Chairman on Board meeting schedules, agendas and materials, and serves as principal liaison between the independent directors and the Chairman. The Lead Independent Director, in consultation with the chairs of the Human Capital and Compensation Committee and the Nominating and Corporate Governance Committee, also leads the process for the evaluation of the Chief Executive Officer.

In addition, the independent directors regularly meet in Executive Sessions without the Chairman, the Chief Executive Officer and other members of management present in accordance with the Company’s Corporate Governance Guidelines.

Risk Management

The Board of Directors takes an active role in overseeing the Company’s financial and non-financial risks. The Audit Committee, which is chaired by Ms. Burgess, leads the Board’s oversight of Company risks. The Audit Committee reviews the Company’s risk assessment and risk management policies and procedures, including those relating to the Company’s enterprise risks, financial risks and information security risks. The Audit Committee receives reports from the Company’s Director of Internal Audit, the Chief Financial Officer, and the General Counsel, all of whom are responsible for various aspects of the Company’s risk management. The Director of Internal Audit reports directly to the Audit Committee. The Audit Committee also meets with the Company’s external auditors separately from management.

The Compliance Committee, which is chaired by Ms. Reed, oversees risk assessment and risk mitigation related to matters within the Compliance Committee’s oversight responsibilities, which may include environmental protection, employee health, safety and security, data privacy, employment, anti-bribery and anti-corruption, product quality compliance, and ethics and compliance training.

The Human Capital and Compensation Committee, which is chaired by Mr. Lawton, takes the lead role in overseeing the management of risks as they relate to the Company’s compensation policies and practices. During 2022, the Human Capital and Compensation Committee reviewed these compensation policies and practices and did not identify any risks that are reasonably likely to have a material adverse effect on the Company.

Executive Sessions

The Company’s Corporate Governance Guidelines require Executive Sessions of independent directors to be held at least once per year. Any independent director can request that additional Executive Sessions be scheduled. In 2022, five Executive Sessions without management were held by

the independent directors and chaired by Mr. Wehmer in his capacity as Lead Independent Director. In addition, Executive Sessions without management were also held after many Board committee meetings during 2022 and were chaired by the respective chairs of the Board committees.

Compensation Committee Interlocks and Insider Participation

The members of the Company’s Human Capital and Compensation Committee in 2022 were Ms. Burgess, Mr. Dearth, Dr. Delgado, Mr. Lawton (Chair), Ms. Reed and Mr. Wehmer. Michael R. Boyce also served as a member of the Human Capital and Compensation Committee until his term as a director ended on April 26, 2022. None of the members of the Human Capital and Compensation Committee during 2022 were at any time an officer or employee of the Company nor did any member participate in a Related Party Transaction. In 2022, none of the Company’s executive officers served as a member of the compensation committee of another entity, or as a director of another entity, one of whose executive officers served on the Human Capital and Compensation Committee or as one of the Company’s directors.

EXECUTIVE COMPENSATION

Compensation Discussion and Analysis

Summary of Executive Compensation in 2022

In 2022, the Company and the Human Capital and Compensation Committee of the Board of Directors (the “Committee”) applied the compensation policies and principles described in this Compensation Discussion and Analysis in determining the compensation for the individuals named in the Summary Compensation Table. Those individuals are referred to herein as the named executive officers (“NEOs”). The NEOs for 2022 were:


NEO		Title
Scott R. Behrens (1)		President and Chief Executive Officer
F. Quinn Stepan, Jr. (2)		Former Chief Executive Officer
Luis E. Rojo		Vice President and Chief Financial Officer
David G. Kabbes		Vice President, General Counsel and Secretary
Arthur W. Mergner		Executive Vice President – Supply Chain
Sean T. Moriarty		Vice President and General Manager – Surfactants

(1)	Mr. Behrens served as the Company’s President and Chief Operating Officer until his promotion to President and Chief Executive Officer on April 25, 2022.

(2)	Mr. Stepan served as the Company’s Chairman and Chief Executive Officer until his retirement on April 25, 2022. Mr. Stepan continues to serve as Chairman of the Company’s Board of Directors.

Significant Achievements and Developments in 2022

Record Company Performance

(1)

In 2022, the Company achieved record net income of $147.2 million, or $6.38 per diluted share, compared to $137.8 million, or $5.92 per diluted share, in 2021, a 7% increase. The Company also achieved record adjusted net income of $153.5 million, or $6.65 per diluted share, versus $143.5 million, or $6.16 per diluted share, in 2021, a 7% increase.¹

(2)

The Surfactant segment delivered operating income of $162.7 million, a 2% decrease versus prior year. The Polymer segment delivered $82.9 million of operating income, a 13% increase versus the prior year. Specialty Product operating income was $29.9 million versus $14.2 million in the prior year.

(3)

For the full year the Company paid $30.6 million of dividends and repurchased $24.9 million of Company stock. With the increased cash dividend in the fourth quarter of 2022, the Company has increased the dividend on its Common Stock for the 55th consecutive year.

Key Developments Impacting Executive Compensation

(1)

The Company’s advisory Say-on-Pay vote was supported by 99% of votes cast at the Company’s 2022 Annual Meeting.

¹ Adjusted net income is a financial measure that has not been calculated pursuant to U.S. generally accepted accounting principles (“GAAP”). See Appendix A for further discussion and a reconciliation of this non-GAAP financial measure to net income, the most directly comparable GAAP financial measure.

(2)

After considering all components of the total compensation paid to the NEOs in 2022, the Committee determined that the 2022 NEO compensation was competitive, reasonable, and aligned with both Company performance and stockholder interests.

Executive Compensation Best Practices the Company Follows


What We Do		What We Don’t Do

✓	Pay for Performance—a Majority of our NEOs’ Annual Total Compensation is Variable and at-Risk	O	No Grants of Discounted Stock Options or Stock Appreciation Rights

✓	Align Executives’ Total Compensation Mix with Stockholders’ Interests	O	No Repricing or Replacing Outstanding Stock Options or Stock Appreciation Rights Without Stockholder Approval

✓	Require Significant Executive Stock Ownership	O	No Employment Agreements That Guarantee Employment or Compensation

✓	Limit Performance-Based Incentive Awards to a Maximum of 200% of Target	O	No Standing Individual Severance or Change-in-Control Agreements

✓	Provide Limited Executive Perquisites	O	No Use of Excise Tax Gross-Ups

✓	Subject Incentive Compensation to a Clawback Policy	O	No Dividend Payments on Unearned Performance Shares

Compensation Philosophy

The basic premise of the Company’s executive compensation philosophy is to pay for performance. The Company’s intention is to foster a performance-driven culture with competitive total compensation as a key driver for all employees. Compensation levels commensurate with Company performance are designed to align the interests of our employees with the interests of our stockholders. To better align our NEOs’ compensation with the interests of our stockholders, a substantial portion of compensation is at-risk and performance-based.

The Company’s guiding philosophy in setting executive compensation is that the compensation of executive officers should reflect the scope of their job responsibilities and the level of individual and corporate performance achieved. Executive compensation should be competitive internally and externally with like or comparable positions based on job descriptions and responsibilities at similarly sized companies within the Company’s industries, and Peer Group (as defined below) and other appropriate related industry data or survey information. The Company’s compensation philosophy is reviewed at least annually by the Committee.

The effectiveness of the executive compensation program is primarily measured by Company performance, stock price appreciation, the ability of the Company to attract and retain executive officers, and comparison against other relevant, external benchmarks as needed.

The Committee generally does not consider the impact of previously awarded compensation in determining current executive total compensation. The Committee does, however, use both a chemical industry peer group as well as aggregate executive compensation survey data to annually assess executive compensation as described below under “Compensation Peer Group and Survey Data.” Except for the limits regarding incentive compensation as described below, the Committee does not use specific policies to allocate between cash and non-cash compensation or between short-term and long-term compensation.

Compensation Objectives

The overall objectives of the Company’s compensation program (in which each NEO participates) are as follows:

•

motivate employees to achieve and maintain a high level of performance, and drive results that will help the Company achieve its goals;

•

align the interests of our employees with the interests of our stockholders;

•

provide for market-competitive levels of compensation; and

•

attract and retain employees of outstanding ability.

Role of the Human Capital and Compensation Committee

The Committee is responsible for overseeing the establishment and administration of the Company’s policies, programs and procedures for compensating the Company’s executive management, as further described below. The Committee is also responsible for providing advice to the Company regarding executive development and succession planning. The Committee may, in its discretion, delegate all or a portion of its duties and responsibilities to a subcommittee or, to the extent permitted by applicable law, to any other body or individual.

Role of the Compensation Consultant

The Committee engaged Exequity LLP (“Exequity”) as its independent compensation consultant for 2022. Exequity advises the Committee on a range of executive compensation matters. The scope of Exequity’s services to the Committee includes, but is not limited to, the following:

•

Providing the Committee with an assessment of the market competitiveness of the Company’s executive compensation.

•

Apprising the Committee of executive compensation-related trends and developments in the marketplace.

•

Informing the Committee of regulatory developments relating to executive compensation practices.

•

Assisting the Committee with goal setting, calibrating levels of pay to various levels of performance, and pay for performance alignment.

•

Comparing Company executive compensation plan designs and practices to the marketplace.

•

Recommending changes to the executive compensation program to maintain competitiveness and ensure consistency with business strategies, good governance practices and alignment with stockholder interests.

Exequity reports directly to the Committee. The Committee conducted its annual assessment of Exequity’s independence pursuant to SEC rules and determined that no conflict of interest exists that would prevent Exequity from independently advising the Committee. Exequity does not provide any other services to management or the Company.

Role of the Committee and Executives in Establishing Executive Compensation

The Committee determines the compensation of the Chief Executive Officer. The Chief Executive Officer and Vice President and Chief Human Resources Officer make recommendations to the Committee regarding compensation for all other executive officers, including the NEOs, other than with respect to their own compensation. The Committee then reviews these recommendations and approves the final compensation for all executive officers. All recommendations made to the Committee and all determinations made by the Committee are based upon the Company’s policies and guidelines and other relevant factors outlined in the “Compensation Peer Group and Survey Data” and “Elements of Compensation” sections below.

Advisory Vote on Executive Compensation

The advisory vote in 2022 was the twelfth consecutive year that the Company’s Say-on-Pay vote was supported by its stockholders with the approval of more than 96% of the votes cast at the annual meeting of stockholders. As discussed above, the Company’s advisory Say-on-Pay vote was supported by 99% of votes cast at the Company’s 2022 Annual Meeting. The Committee acknowledges and values the feedback from the Company’s stockholders on the annual Say-on-Pay vote and believes that these results demonstrate stockholder support of the Company’s executive compensation programs. As a result of the strong stockholder support for the 2022 Say-on-Pay vote, the Committee determined that the Company’s compensation practices and processes did not require any significant modifications to achieve the desired results of the Company’s compensation program or to address stockholder concerns and therefore did not make any changes as a direct result of such vote results. The Committee will continue to consider the outcome of these advisory votes when determining future executive compensation arrangements.

Executive Pay Mix

The Company targets a total compensation mix where fixed pay, consisting of base salary, is less than half of the total compensation that any NEO or executive officer may earn in any given year. The combined mix of both short-term and long-term incentives for executive officer compensation is structured to encourage the necessary focus and motivation to achieve outstanding results on an ongoing basis, both in the short term and long term. In addition, the combined focus on both short-term and long-term objectives is designed to align executive officers’ and stockholders’ interests. Short-term incentives for executive officers are based on individual and Company performance. Long-term incentives for executive officers are based only on Company performance. The Company’s total compensation targets assume above-average Company performance, and potential compensation can vary considerably depending on overall Company performance. The graphics below illustrate the pay mix for our Chief Executive Officer (Mr. Behrens) and other NEOs other than Mr. Stepan (on an average basis) using target level of performance for all incentive awards.

LOGO

Compensation Peer Group and Survey Data

To better understand the compensation practices of similar companies, the Committee reviews data gathered from a custom peer group (“Peer Group”) and general market survey data from Mercer LLC (“Mercer”). Information gathered from the Peer Group serves as the primary reference point for the Committee, with Mercer survey data used as a secondary reference.

The Peer Group consists of companies selected on the basis of chemical industry affiliation and size as compared to the Company (e.g., total revenues and market capitalization). The following companies comprised the Peer Group that the Committee referenced when setting 2022 compensation:


AdvanSix Inc.	Ecovyst Inc.	Kraton Corporation
Albemarle Corporation	Ferro Corporation	NewMarket Corporation
Ashland Inc.	H.B. Fuller Company	Quaker Chemical Corporation
Avient Corporation	Innospec Inc.	RPM International Inc.
Cabot Corporation	Koppers Holdings, Inc.	Sensient Technologies Corporation

The Committee undertakes annual evaluations of the Peer Group in order to ensure the Company is comparing itself with companies that have the characteristics to appropriately match the Company. Exequity performed a review of the Peer Group listed above in July 2022 and, as a result of such review, the Committee removed Kraton Corporation from the Peer Group due to acquisition and removed Ecovyst Inc. and Ferro Corporation due to size. In addition, the Committee removed

Albemarle Corporation and added The Chemours Company due to a stronger business fit. The Committee and its independent compensation consultant will continue to monitor the Peer Group going forward as appropriate.

When assessing the competitiveness of Company compensation programs, the Committee, in part, uses median compensation levels in the Peer Group as a reference point to provide a framework for and on which to base individual compensation decisions. The Committee generally references median total compensation for executive officers, but the Committee retains discretion to determine appropriate compensation levels. The Committee believes that all NEOs’ and executive officers’ total compensation amounts are within appropriate and reasonable levels as compared to the Peer Group data considering performance, experience level, time in position and both external and internal equity evaluations.

Elements of Compensation

For the fiscal year ended December 31, 2022, the principal elements of compensation for the executive officers, including the NEOs, were as follows:



Compensation Element

Purpose		Description

Base Salary

To attract and retain employees of outstanding abilities		Fixed component of pay based on specific position salary ranges determined by job responsibilities and performance, and reference to Peer Group data

Short-Term Incentive Compensation

To drive improvement in year-over-year financial performance; to motivate, attract and retain employees; and to align executives’ interests directly with Company financial objectives		Variable, annual, at-risk cash component of pay that rewards achievement of pre-determined Company and individual goals

Long-Term Incentive Compensation

To promote retention of executives, to reward outstanding Company performance, to encourage a focus on the Company’s long-term financial results, and to align executive interests with stockholder interests		Variable, at-risk, equity component of pay for eligible participants that rewards stockholder value creation over the long term



Compensation Element

Purpose		Description

Retirement Benefits, Perquisites and Other Benefits

To promote retention, to attract outstanding employees and to provide employees with a tax deferred retirement savings vehicle directly connected to the Company’s financial results		Company dollar-for-dollar matching contribution up to six percent of base salary under a Savings and Investment Retirement Plan for all U.S. employees, plus supplemental contributions based on the Company’s financial results Executives and key employees, including the NEOs, are eligible for a limited amount of perquisites Benefit programs that are available to all U.S. salaried employees

Base Salary

The Company has established salary grades and ranges for all global employees, including the NEOs. Salary grades reflect the responsibility level of the position, i.e., positions with a greater level of responsibility have a higher salary grade. The salary range for each grade is primarily based on survey data. The salary grade structure enables the Company to ensure that pay is both market competitive and internally equitable.

The Committee, taking into consideration the performance of the Company, the Company’s compensation philosophy, the Peer Group data, and the executive’s performance, reviews and determines the Chief Executive Officer’s salary on an annual basis. The Chief Executive Officer and the Vice President and Chief Human Resources Officer make recommendations to the Committee regarding compensation for all other NEOs. The Committee has the discretion to approve such recommendations or revise the recommended amounts, higher or lower, based upon each executive officer’s individual performance. The Chief Executive Officer’s salary range is determined based on the same factors and criteria as those for the other NEOs and executive officers.

The NEOs’ base salaries, effective as of March 1, 2022 (unless otherwise noted), are shown below. Mr. Behrens’ base salary was increased significantly in connection with his promotion to Chief Executive Officer of the Company to reflect additional responsibilities associated with such role and to align his pay with the market rates for such position. The other NEOs’ base salaries were increased slightly to bring them more in line with the market (other than Mr. Stepan, who did not receive a base salary increase in 2022).


NEO	2021 Base Salary		2022 Base Salary
Scott R. Behrens	$	500,000	$	900,000(1)
F. Quinn Stepan, Jr.	$	1,000,000	$	1,000,000
Luis E. Rojo	$	475,000	$	515,000
David G. Kabbes	$	430,000	$	445,000
Arthur W. Mergner	$	465,000	$	480,000
Sean T. Moriarty	$	425,000	$	440,000

(1)	Effective as of April 26, 2022, in connection with Mr. Behrens’ promotion to Chief Executive Officer.

Short-Term Incentive Compensation

NEOs and certain other employees are eligible for short-term incentive compensation as set forth in the Management Incentive Plan. The purpose of the Company’s short-term incentive compensation program is to promote improvement in year-over-year financial performance; to motivate, attract and retain executive, managerial and key employees of outstanding ability; and to align participants’ interests directly with the Company’s financial targets. The target amount of short-term incentive compensation for each NEO is expressed as a percentage of the executive’s actual base salary earned during the respective calendar year. Because senior managers have a greater ability to impact Company results, a significant percentage of their total target compensation is at-risk. The Chief Executive Officer position has the highest level of responsibility, and therefore, the target percentage exceeds the other NEOs’ target percentages.

The extent, if any, to which an incentive award will be payable to an NEO will be based solely upon the degree of achievement of pre-established performance goals over the specified calendar year. In years when Company performance is exceptional and above the Target level, it is possible for NEOs to receive annual incentive payments above Target, while in years when Company or individual performance is below the Threshold level for a particular metric, no annual incentive will be paid based upon performance on that metric. In addition, the Committee may, in its sole discretion, reduce or eliminate the amount that would otherwise be payable to the NEO with respect to a calendar year.

The following chart reflects the Target Annual Incentive Award and Maximum Annual Incentive Award for each NEO for 2022 under the terms of the Management Incentive Plan (which target amounts were the same as for 2021):


NEO	Target Annual Incentive Award(% of 2022 Salary Earned)			Maximum Annual Incentive Award(% of 2022 Salary Earned)
Scott R. Behrens,		100.0	%		200.0	%
F. Quinn Stepan, Jr.		100.0	%		200.0	%
Luis E. Rojo		75.0	%		150.0	%
David G. Kabbes		65.0	%		130.0	%
Arthur W. Mergner		75.0	%		150.0	%
Sean T. Moriarty		75.0	%		150.0	%

Each NEO’s annual incentive payment is determined based on the Company’s achievement of overall financial performance objectives (“Corporate Financial Performance Objectives”) and the achievement of individual performance objectives (“Individual Performance Objectives”), as described below. For 2022, each NEO’s Annual Incentive Award could be increased by a prorated amount if Corporate Net Income exceeded the Target objective, with a two times multiplier applied if Corporate Net Income met or exceeded the Maximum objective.

Corporate Financial Performance Objectives

The Committee establishes the Corporate Financial Performance Objectives at the beginning of each calendar year. For 2022, the Committee established targets for the two Corporate Financial Performance Objectives for all NEOs: Corporate Net Income and Corporate Growth Goal.²

For 2022, the following performance levels were established for the Corporate Net Income objective:


	Threshold	Target	Maximum
Corporate Net Income	$115.0 million	$145.0 million	$160.0 million

² Corporate Net Income is a non-GAAP measure that differs from the Company’s reported net income. See Appendix A for a definition.

The Corporate Growth Goal consisted of profit goals for three categories of products and customers. Together, the three categories of products and customers had an assigned profit goal, with a target increase over 2021 profit. The Corporate Growth Goal was based upon strategic growth priorities for the Company, and was designed to be difficult but achievable. The Corporate Growth Goal consisted of the following categories: Rigid Polyols, Functional Surfactants and Tier 2 and Tier 3 Surfactants Customers.

For 2022, the following performance levels were established for the Corporate Growth Goal with reference to the profit achieved:


	Threshold	Target
Corporate Growth Goal	$595.5 million	$644.5 million

Each NEO’s annual incentive objectives include these Corporate Financial Performance Objectives. For 2022, all NEOs had at least 30% of their annual incentives tied to these objectives. Within the Corporate Financial Performance Objectives, an 80% weighting was assigned to the Corporate Net Income objective and a 20% weighting was assigned to the Corporate Growth Goal objective.

The following table shows the Company’s performance against the Corporate Net Income and Corporate Growth Goal objectives in 2022:


Objective	2022 Results	2022 Target	2022 Performance Against Target
Corporate Net Income	$ 153.5 million	$ 145.0 million	100%
Corporate Growth Goal	$ 694.1 million	$ 644.5 million	100%

For 2022, the Company exceeded the Corporate Net Income Target objective of $145.0 million, with a result of $153.47 million, and exceeded the Corporate Growth Goal Target objective of $644.5 million, with a result of $694.1 million. In addition, based on the amount by which the Company exceeded the Corporate Net Income Target objective, the NEOs’ Annual Incentive Awards were multiplied by 156.5%. The multiplier for performance above the Target objective was determined by straight line interpolation.

Individual Performance Objectives

The former Chief Executive Officer, the President and Chief Executive Officer and the Committee agreed upon the Individual Performance Objectives for the former Chief Executive Officer and the President and Chief Executive Officer at the beginning of 2022. For executives other than the Chief Executive Officer, the Chief Executive Officer and the executive agree upon Individual Performance Objectives at the beginning of each calendar year. These Individual Performance Objectives may either be financial objectives for a particular business segment or organization, or achievement of certain financial, cultural, safety, service or other strategic objectives specific to their function and responsibility. The Chief Executive Officer’s Individual Performance Objectives include enhancing long-term Company performance by championing core culture and values, including safety, compliance, and employee engagement and accountability. For each business segment leader, the financial performance of the executive’s segment comprises a significant portion of the executive’s Individual Performance Objectives. For example, for 2022, global surfactant operating income comprised 40% of the short-term incentive compensation objectives for Mr. Moriarty, the Company’s Vice President and General Manager – Surfactants.

For 2022, the Corporate Financial Performance Objective and Individual Performance Objective Target payouts and results (as percentages of salary earned in 2022) for the NEOs were as follows:


							Individual Objectives (2)
	Corporate Financial Performance Objectives						Safety and Compliance Objectives (1)						Other Individual Objectives (2)
NEO	Target			Result			Target			Result			Target			Result
Scott R. Behrens		80.00	%		80.00	%		—			—			20.00	%		10.00	%
F. Quinn Stepan, Jr.		80.00	%		80.00	%		—			—			20.00	%		20.00	%
Luis E. Rojo		45.00	%		45.00	%		—			—			30.00	%		21.50	%
David G. Kabbes		30.00	%		30.00	%		7.50	%		7.50	%		27.50	%		24.00	%
Arthur W. Mergner		34.00	%		34.00	%		7.00	%		7.00	%		34.00	%		14.33	%
Sean T. Moriarty		25.00	%		25.00	%		5.00	%		5.00	%		45.00	%		23.59	%

(1)	The objective consisted of the global recordable injury rate and additional environmental compliance goals. The Company’s global recordable injury rate was a record 0.42 in 2022.

(2)	Individual objectives include cultural, safety, sustainability, corporate development, financial, compliance and strategic initiative goals that relate to each executive’s areas of responsibility.

The following chart reflects the total Corporate Financial Performance Objective and Individual Performance Objective results, and the resulting Annual Incentive Award earned for each NEO for 2022 under the terms of the Management Incentive Plan. Because the Company’s Corporate Net Income result in 2022 exceeded the Target objective, the payouts earned based on Corporate Financial Performance Objective and Individual Performance Objective results were multiplied by 156.5%. The amounts earned by the NEOs under the Company’s short-term compensation program for 2022 are set forth in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table.


NEO	Corporate Financial Performance Objectives and Individual Objectives Results (% of 2022 Salary Earned)			Annual Incentive Award Earned (% of 2022 Salary Earned)
Scott R. Behrens,		90.00	%		140.85	%
F. Quinn Stepan, Jr.		100.00	%		156.50	%
Luis E. Rojo		66.50	%		104.07	%
David G. Kabbes		61.50	%		96.25	%
Arthur W. Mergner		55.33	%		86.59	%
Sean T. Moriarty		53.59	%		83.87	%

Long-Term Incentive Compensation

The Committee typically grants equity awards annually to the NEOs under the Company’s long-term incentive plan. In 2022, the Committee reviewed and approved an allocation of long-term incentives for the NEOs at approximately 60% of the total grant value as SARs and approximately 40% of the total grant value as performance shares. The Committee changed the equity award mix to eliminate options in 2022 in order to better align with market practice. The value of Mr. Behrens’ long-term incentive award was increased in connection with his promotion to Chief Executive Officer of the Company to

reflect additional responsibilities associated with such role and to align his compensation with the market rates for such position.


NEO	Stock Appreciation Rights Value		Performance Shares Value		Total 2022 LTI Value
Scott R. Behrens	$	900,000	$	600,000	$	1,500,000
F. Quinn Stepan, Jr.		—		—		—
Luis E. Rojo	$	480,000	$	320,000	$	800,000
David G. Kabbes	$	360,000	$	240,000	$	600,000
Arthur W. Mergner	$	405,000	$	270,000	$	675,000
Sean T. Moriarty	$	360,000	$	240,000	$	600,000

The chart below shows the number of each type of equity award that the Committee granted to the NEOs as part of the annual 2022 equity grant. The number of SARs granted was calculated by dividing the amounts in the table above by the Black-Scholes value of a SAR on the date of the grant. The number of performance shares granted was calculated by dividing the amounts in the table above by the average of the opening price and closing price of the Company’s common stock on the date of the grant.


NEO	Stock Appreciation Rights		Performance Shares (at Target)
Scott R. Behrens		25,217		5,393
F. Quinn Stepan, Jr.		—		—
Luis E. Rojo		13,449		2,876
David G. Kabbes		10,087		2,157
Arthur W. Mergner		11,348		2,427
Sean T. Moriarty		10,087		2,157

The grants of SARs and performance share awards to the NEOs are shown in the Grants of Plan-Based Awards Table. The Board of Directors believes that the mix of such awards provides long-term incentive compensation that is market competitive to attract and retain executives who drive the long-term growth of the Company and further align the interests of those executives with the interests of the Company’s stockholders.

In addition to the annual long-term incentive awards, grants of SARs, performance shares and other stock awards may be awarded to executive officers at other times based on factors that the Committee determines to be relevant, including upon hire, upon promotion or for extraordinary job performance. Upon his promotion to President and Chief Executive Officer, Mr. Behrens was awarded the following grants in April 2022.


NEO	Stock Appreciation Rights Value		Performance Shares Value		Total Grant Value
Scott R. Behrens	$	900,000	$	600,000	$	1,500,000

The chart below shows the number of each type of equity award the Committee granted to Mr. Behrens in April 2022 in connection with his promotion to President and Chief Executive Officer.


NEO	Stock Appreciation Rights		Performance Shares (at Target)
Scott R. Behrens		27,003		6,122

Stock Appreciation Rights

SARs are granted annually at the average of the opening price and closing price of Common Stock on the date of the grant and have a ten-year term. SARs vest ratably over a three-year period and are settled in stock.

Stock Awards (Performance Shares)

Performance shares are contingently awarded at a target number of shares and subject to certain performance conditions established by the Committee. The Committee chose Corporate Net Income as a performance measure because the Company uses net income as an important indicator of business performance. The Company uses an adjusted measure, rather than reported net income, because the adjusted measure excludes items that may not be indicative of the Company’s core operating results. The initial target number of shares may increase or decrease by up to 50% based on the Company’s Corporate Net Income results for the calendar year in which the grant is made versus Threshold, Target and Maximum Corporate Net Income objectives. If the Company’s Corporate Net Income result for such year is below the Threshold objective, then the performance shares are forfeited entirely. If the Company’s Corporate Net Income result for such year exceeds the Maximum objective, then the target number of shares will be increased by 50%. Following completion of the three-year performance period, the number of shares may further increase or decrease by up to 30%, based on a three-year average Corporate Return on Invested Capital (“ROIC”) modifier.³ For the performance shares granted in 2022, the initial calculation of the number of performance shares was based on the following Corporate Net Income objectives:


Performance Level	2022 Corporate Net Income		Initial Share Award (% of Target)
Threshold	$	115 million	50%
Target	$	145 million	100%
Maximum	$	160 million	150%

The Company will determine the actual number of performance shares issued after the three-year performance period ending December 31, 2024, based on the following ROIC modifiers:


2022-2024 Average ROIC		Award Modifier
Less than or equal to 8.00%		-30%
8.70%		No impact
Equal to or greater than 9.50%		+30%

The 2022 Corporate Net Income result of $153.5 million was above the Target objective level. Therefore, the number of shares ultimately earned and issued for the 2022 grant will be 128.25% of the initial target number of shares, as increased or decreased up to 30% by the ROIC modifier described above and calculated over the three-year period ending December 31, 2024.

Retirement Benefits

Retirement Plan for Salaried Employees

Effective June 30, 2006, the Company froze the Retirement Plan for Salaried Employees (the “Retirement Plan for Salaried Employees”) and ended the benefit accrual for all participants. Eligible participants were all employees not covered by a collective bargaining agreement who were employees prior to July 1, 2006. The Retirement Plan for Salaried Employees was replaced by the

³ Return on Invested Capital is a non-GAAP measure. See Appendix A for a definition.

Savings and Investment Retirement Plan (“SIRP”), which provides for Company contributions into the employee’s SIRP account (see the discussion below in the “Savings and Investment Retirement Plan” section). The primary purpose of both the Retirement Plan for Salaried Employees and the SIRP is to retain valuable employees.

The amounts included in the Pension Benefits table are the present values of the benefits expected to be paid under the Retirement Plan for Salaried Employees in the future. The amount of each future payment is based on the current accrued pension benefit. The actuarial assumptions, with the exception of the expected retirement age, are consistent with those used in the Company’s financial statements. The retirement age is the earliest unreduced retirement age as defined in the Retirement Plan for Salaried Employees and the SIRP.

The pension benefit information set forth in this proxy statement has been calculated based on actuarial assumptions that are considered to be reasonable. Other actuarial assumptions could also be considered to be reasonable, which would result in different pension benefit estimates.

Supplemental Executive Retirement Plan

NEOs participate in the same basic retirement plans as all other employees, with the exception of the former Chief Executive Officer, who is also currently eligible for benefits under the Supplemental Executive Retirement Plan (“SERP”). The SERP was created to provide supplemental retirement benefits to any executive affected by IRS limits on benefits that otherwise would be available through the Retirement Plan for Salaried Employees. The benefits are calculated according to the same retirement plan formula that applies to all eligible employees. The Company believes that all elements of the SERP are customary for this type of retirement plan. The SERP was frozen as of June 30, 2006. The funding status of the SERP is reviewed periodically. Currently, the Company has elected not to fund the SERP.

Savings and Investment Retirement Plan

Pursuant to the SIRP, in each payroll period during 2022, the Company made a contribution to the SIRP account of each eligible employee, including the NEOs. The amount of the Company contribution in 2022 was a dollar-for-dollar matching contribution of up to six percent of the participant’s base salary for the portion of the payroll period during which the participant was an eligible employee (subject to certain limits). All the NEOs received SIRP contributions in 2022 in the amounts set forth in the Summary Compensation Table.

Profit-Sharing Contributions

The Company may make additional profit-sharing contributions under the SIRP to each eligible employee, including the NEOs and salaried, hourly and union employees. The Company’s profit-sharing contributions are designed to (i) provide eligible employees with an element of their retirement savings that is directly connected to the Company’s financial results, (ii) provide a tax-deferred retirement savings vehicle for eligible employees while giving participants the incentive to optimize the Company’s financial results, and (iii) allow eligible employees to enjoy the benefits of the Company’s success.

Each year management determines, based on the Company’s financial results, whether to recommend to the Committee that the Company make a profit-sharing contribution to the accounts of eligible participants. The Committee reviews management’s recommendation and, if approved, presents the recommendation to the Board of Directors for approval. In 2022, the Committee recommended a profit-sharing contribution that is based on 2.5% of the Company’s pre-tax income.

Employee Stock Ownership Plan

The Stepan Company Employee Stock Ownership Plan II (“ESOP II”), which is applicable to NEOs, is designed to (i) expand stock ownership among employees, (ii) encourage greater employee interest in the Company’s financial results, (iii) benefit employees financially by enabling them to acquire shares of the Company’s Common Stock without making contributions, and (iv) provide eligible employees with the opportunity to share in the growth of the Company.

Contributions to ESOP II are a part of the profit sharing contribution under the SIRP as described in the “Profit Sharing Contributions” section above and may be reallocated to ESOP II in shares of Company Common Stock. The ESOP II allocation is made to broaden Company stock ownership among employees for further alignment with the interests of Company stockholders. For 2022, the Committee approved a 100% reallocation to ESOP II.

Supplemental Executive Savings and Investment Retirement Contributions

The Board of Directors has the authority to approve supplemental contributions to provide retirement benefits to any executive affected by IRS limits on benefits that otherwise would be available through contributions to the SIRP. The supplemental contributions are provided to executives as a common executive benefit that allows the Company to be competitive for executive compensation and benefits. During 2022, all the NEOs were eligible to receive supplemental contributions in the amount by which a six percent contribution to the NEO’s SIRP account by the Company would exceed IRS limits. All supplemental contributions to the NEOs in 2022 are included in the Summary Compensation Table.

Perquisites

The Company provides NEOs with limited perquisites that the Company and the Committee believe are reasonable and consistent with the Company’s overall compensation program because they better enable the Company to attract and retain superior employees for key positions. The Committee periodically reviews the perquisites provided to the NEOs and other executives.

The Company offers additional long-term disability “top-up” coverage to employees, including NEOs, whose long-term disability coverage is limited due to payout caps under the long-term disability coverage offered to all U.S. salaried employees.

All executives at the Vice President level and higher, including the NEOs, are provided the use of Company-leased vehicles, including fuel, maintenance and insurance. The allowance for the initial vehicle cost is set by salary grade. The personal use value is computed using the IRS annual lease valuation rule. Other travel benefits, including spousal travel on a limited basis, are provided periodically. The Company also provides relocation benefits for newly hired executive officers.

The Company maintained one Company-owned property that is not used solely for business purposes. Executives, including the NEOs, are allowed to use this property for personal use if and when the property is not needed for business purposes. When the NEOs use this property for personal reasons, such values are included in the Summary Compensation Table under “All Other Compensation” based on the incremental cost to the Company.

In addition, the Company paid club membership dues for the former Chief Executive Officer that were not exclusively used for business entertainment. The actual cost paid for club membership dues is included in the Summary Compensation Table under “All Other Compensation.”

Clawback Policy

The Company has adopted a Clawback Policy that applies to the Company’s executive officers who are subject to Section 16 of the Exchange Act. Under this policy, in the event that any executive covered by the policy engages in willful misconduct or fraud that substantially contributes to a material restatement of the Company’s financial statements, the Company will recover from all covered executives’ compensation that would not have been paid had the restated financial statements initially been correct. The compensation that could be recovered includes short-term and long-term incentive compensation awarded based on the subsequently restated financial statements that was paid during the 12 months preceding the restatement. The Company plans to modify its Clawback Policy as needed to comply with new SEC regulations and New York Stock Exchange Listing Standards.

Stock Ownership Policy

The NEOs are subject to a stock ownership policy. The Company instituted a stock ownership policy because it believes that ownership of Company stock is desirable in order to focus both short-term and long-term decision-making on the best interests of the Company and its stockholders. Ownership of Company stock aligns NEOs’ interests with the Company’s financial performance, including the performance of the Company’s Common Stock.

The stock ownership policy, last amended in December 2022, is reviewed by the Committee, as needed, on a periodic basis against general industry benchmarks of stock ownership.

The stock ownership guidelines apply to all NEOs and certain other employees. The Company’s Chief Executive Officer is required to maintain ownership of shares with a value of at least five times his base salary; each other executive officer is required to maintain ownership of shares with a value of at least two and a half times his or her base salary; and each other participant is required to maintain ownership of shares with a value of at least one times his or her base salary. All executives, including the NEOs, are expected to reach and maintain the required stock ownership level within five years from their initial stock grant. In the event of a promotion that would require an increase in stock ownership under the terms of the policy, an executive has five years from the date of the promotion to achieve compliance with the new level of stock ownership requirements. During the first thirty-six months of eligibility, all executives, including the NEOs, are encouraged, but not required, to progress toward compliance by making approximately 20% progress each year. After thirty-six months of eligibility, all executives, including the NEOs, are required to demonstrate progress toward the stock ownership requirement by attaining eighty percent of the required level by year four and one hundred percent of the required level by year five. Recognizing the importance of retirement planning, an NEO may, commencing at age 61, reduce his or her holdings by 20% per year to a minimum of fifty percent of his or her required ownership level by the calendar year he or she attains the age of 65.

The following shares count towards the stock ownership requirements: (i) shares owned directly or by any immediate family member, (ii) shares owned indirectly as trustee or custodian for the benefit of children, (iii) shares owned in the Company’s ESOP II, (iv) shares owned in the Company’s Employee Stock Purchase Plan, (v) shares held in any Company deferred compensation plan, (vi) unvested performance shares (with the amount of shares counted adjusted based on actual net income performance and potential ROIC performance), and (vii) unvested restricted stock units. Grants of stock options and SARs do not count towards the stock ownership requirement unless exercised. No shares other than those stated above count toward the stock ownership requirements.

The Committee reviews annually whether executives, including the NEOs, are in compliance with the stock ownership policy. The Committee determined that all executive officers, including the NEOs, were in compliance with the Company’s stock ownership requirements as of March 2023. Executive

officers who received their initial stock grant over five years ago are in full compliance and executive officers who received their initial stock grant within the last five years have made the requisite progress towards full compliance. If an executive fails to comply with stock ownership policy and annual progress requirements, the executive must retain 100% of their vested long-term incentive plan shares. In addition, all executives, including NEOs, are prohibited from selling Company stock acquired by exercising stock options until such executive is in compliance with the ownership requirement.

Hedging and Trading Restrictions

The Company has an Insider Trading Policy that, among other things, prohibits NEOs, officers, directors and employees from hedging the economic risk of their ownership in the Company’s Common Stock. This policy bars NEOs, officers, directors and employees from purchasing financial instruments or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Company equity securities granted by the Company as compensation or held, directly or indirectly, by the NEO officer, director or employee. In addition, this policy prohibits short-selling of the Company’s securities. This policy also prohibits directors, officers and covered employees from trading in the Company’s securities outside of trading window periods or without pre-clearance.

Post-Termination Benefits

The Company does not maintain any plans or other arrangements with its executives that provide for severance or post-termination compensation in the event of a future termination of the executive’s employment. Subject to Committee approval, the Company may, however, occasionally enter into separation agreements or arrangements with its executives at the time of the executive’s termination of employment that provide for severance payments or benefits. In addition, executives and other employees may receive accelerated vesting of equity awards in the event of death or disability, and prorated accelerated vesting of equity awards in the event of retirement, pursuant to the terms of the applicable grant agreements.

Impact of Tax and Accounting Considerations

The Company monitors compensation and benefits-related accounting rules, securities rules, tax rules and all other federal and state regulations on an ongoing basis through internal sources and external sources such as consultants, advisors and outside legal counsel. The Company routinely considers such rules and regulations and their impact on plan design alternatives and Company performance.

Human Capital and Compensation Committee Report

The Human Capital and Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with the management of the Company. Based on this review and discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in the proxy statement and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

HUMAN CAPITAL AND COMPENSATION COMMITTEE


		Gregory E. Lawton, Chair
		Lorinda A. Burgess
		Randall S. Dearth
		Joaquin Delgado
		Jan Stern Reed
		Edward J. Wehmer

2022 Summary Compensation Table

The table below summarizes the total compensation paid to or earned by each of the NEOs for the fiscal years ended on December 31, 2020, December 31, 2021, and December 31, 2022. Additional information related to each component of compensation for the NEOs is provided above in the Compensation Discussion and Analysis.


Name and Principal Position	Year		Salary (1)		Stock Awards (2)		Option Awards (3)		Non-Equity Incentive Plan Compensation (4)		Change in Pension Value and Nonqualified Deferred Compensation Earnings (5)		All Other Compensation (6)		Total
Scott R. Behrens President and Chief Executive Officer		2022	$	780,833	$	1,152,739	$	1,800,005	$	1,099,840		—	$	125,929	$	4,959,346
		2021	$	500,000	$	387,216	$	600,005	$	417,240		—	$	66,948	$	1,971,409
		2020	$	432,500	$	231,550	$	360,012	$	620,292	$	45,588	$	58,556	$	1,748,498

F. Quinn Stepan, Jr. Chairman and Chief Executive Officer		2022	$	724,518	$	1,471,966	$	1,932,410	$	521,668		—	$	95,107	$	4,745,669
		2021	$	1,000,000	$	1,316,512	$	2,040,010	$	900,241		—	$	124,200	$	5,380,963
		2020	$	993,333	$	1,157,751	$	1,800,009	$	1,966,802	$	287,035	$	125,715	$	6,330,646

Luis E. Rojo Vice President and Chief Financial Officer		2022	$	508,333	$	307,588	$	479,995	$	529,036		N/A	$	66,650	$	1,891,602
		2021	$	468,333	$	261,338	$	405,003	$	315,194		N/A	$	56,248	$	1,506,116
		2020	$	430,833	$	231,550	$	360,012	$	616,092		N/A	$	53,782	$	1,692,270

David G. Kabbes Vice President, General Counsel and Secretary		2022	$	442,500	$	230,691	$	360,005	$	425,896		N/A	$	62,694	$	1,521,786
		2021	$	427,000	$	193,548	$	299,984	$	253,997		N/A	$	50,529	$	1,225,058
		2020	$	410,000	$	192,959	$	300,036	$	496,102		N/A	$	289,172	$	1,688,269

Arthur W. Mergner Executive Vice President – Supply Chain		2022	$	477,500	$	259,568	$	405,010	$	413,475		—	$	62,865	$	1,618,418
		2021	$	465,000	$	261,338	$	405,003	$	252,319		—	$	55,059	$	1,438,719
		2020	$	427,500	$	231,550	$	360,012	$	557,034	$	65,404	$	52,825	$	1,694,326

Sean T. Moriarty Vice President and General Manager – Surfactants		2022	$	437,500	$	230,691	$	360,005	$	366,891		—	$	63,566	$	1,458,653
		2021	$	425,000	$	232,354	$	360,047	$	236,938		—	$	55,557	$	1,309,896
		2020	$	372,500	$	173,712	$	270,009	$	384,794	$	46,970	$	50,452	$	1,298,437

(1) Amount for 2022 for Mr. Stepan includes (a) vacation payout in the amount of $147,435 upon retirement, (b) fees for his service as non-executive Chairman of the Board of Directors after his retirement on April 25, 2022, in the amount of $168,750 and (c) a prorated portion of the annual retainer fee for his service as a director after April 25, 2022 in the amount of $75,000.

(2) Amount for Mr. Stepan includes the annual stock award for Non-Employee Directors. The stock award was granted in April 2022 and was vested upon grant. Each Non-Employee Director was awarded 1,249 shares. The value is based on the market value of the Company’s Common Stock of $100.01, the average of the opening and closing prices of Common Stock on the day of the grant in accordance with FASB ASC Topic 718. Amount for Mr. Stepan also includes the value of performance shares the Company modified to remain outstanding following Mr. Stepan’s retirement, calculated in accordance with FASB ASC Topic 718.

For NEOs other than Mr. Stepan, amounts for 2022 are performance share awards that are subject to performance-based vesting conditions and reflect the target outcome award value at the date of the grant in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. See Note 11, Stock-based Compensation, to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, for a discussion of relevant assumptions used in calculating the fair values pursuant to ASC Topic 718. These performance share awards are subject to achievement of the performance conditions as described in the section above entitled “Compensation Discussion and Analysis—

Elements of Compensation—Long-Term Incentive Compensation.” The maximum grant date values, assuming achievement of the highest level of performance conditions, would be:


Name	2022
Scott R. Behrens	$	2,247,841
F. Quinn Stepan, Jr.		—
Luis E. Rojo	$	599,797
David G. Kabbes	$	449,848
Arthur W. Mergner	$	506,157
Sean T. Moriarty	$	449,848

(3) Amount for Mr. Stepan consists of the value of options and SARs the Company modified to accelerate vesting following Mr. Stepan’s retirement, calculated in accordance with FASB ASC Topic 718.

For NEOs other than Mr. Stepan, amounts for 2022 include the grant date fair value of SARs granted during the fiscal year ended December 31, 2022, calculated in accordance with FASB ASC Topic 718. See Note 11, Stock-based Compensation, to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, for a discussion of relevant assumptions used in calculating the fair values pursuant to ASC Topic 718.

(4) Amounts for 2022 reflect annual incentive awards earned pursuant to the Management Incentive Plan with respect to 2022 performance, which were paid in March 2023.

(5) Amounts for 2022 are reported at zero due to an actuarial decrease in the present value of the NEO’s benefits under the Company’s pension plan determined using interest rate and mortality rate assumptions consistent with those used in the Company’s financial statements. Pension values decreased by the following amounts during 2022: Mr. Behrens: $100,457; Mr. Stepan: $518,116; Mr. Mergner: $137,543; and Mr. Moriarty: $103,529.

(6) Amounts for 2022 include Company contributions to each NEO’s defined contribution accounts as follows: Mr. Behrens: $72,165; Mr. Stepan: $30,807; Mr. Rojo: $46,980; Mr. Kabbes: $40,896; Mr. Mergner: $44,131; and Mr. Moriarty: $40,434. Amounts for 2022 also include personal use of Company-leased vehicles. Amounts for 2022 for NEOs other than Mr. Stepan also include long-term disability insurance premiums; such premiums amounted to $26,828 for Mr. Behrens. Amounts for 2022 for NEOs other than Mr. Stepan also include spousal travel. Amount for 2022 for Mr. Stepan also includes club membership dues, the value of vehicle previously leased by the Company that was transferred to Mr. Stepan in connection with his retirement ($49,737) and retirement gifts. The amount of perquisites and other personal benefits provided to Mr. Stepan for 2022 totaled $64,301. Amount for 2022 for Mr. Behrens also includes personal and family use of entertainment events. Amount for 2022 for Mr. Mergner also includes personal and family use of Company-owned property.

2022 Grants of Plan-Based Awards


	Type of Award (1)	Grant Date (2)		Estimated Possible Payouts Under Non-Equity Incentive Plan Awards						Estimated Future Payouts Under Equity Incentive Plan Awards						All Other Stock Awards: Number of Shares of Stock or Units (#) (4)		All Other Option Awards: Number of Securities Underlying Options (#)		Exercise or Base Price of Option Awards ($/Sh) (5)		Grant Date Fair Value of Stock and Option Awards ($) (6)
Name	Type of Award (1)	Grant Date (2)		Threshold ($)		Target ($) (3)		Maximum ($)		Threshold (#)		Target (#)		Maximum (#)						Exercise or Base Price of Option Awards ($/Sh) (5)		Grant Date Fair Value of Stock and Option Awards ($) (6)
Scott R. Behrens	MIP		—	$	0	$	780,833	$	1,561,666
	SA		2/16/2022								2,697		5,393		10,516							$	576,781
	SAR		2/16/2022																25,217	$	111.26	$	899,995
	SA		4/25/2022								3,061		6,122		11,938							$	575,958
	SAR		4/25/2022																27,003	$	98.00	$	900,010

F. Quinn Stepan, Jr.	MIP		—	$	0	$	1,000,000	$	2,000,000
	SA		4/25/2022								5,865		11,730		22,874							$	589,174
	SA		4/25/2022								5,496		10,992		21,434							$	757,880
	SAR		4/25/2022																11,570	$	102.30	$	406,223
	SAR		4/25/2022																18,635	$	123.73	$	559,982
	NQS		4/25/2022																11,570	$	102.30	$	406,223
	NQS		4/25/2022																18,635	$	123.73	$	559,982
	DSA		4/26/2022														1,249					$	124,912

Luis E. Rojo	MIP		—	$	0	$	381,250	$	762,500
	SA		2/16/2022								1,438		2,876		5,608							$	307,588
	SAR		2/16/2022																13,449	$	111.26	$	479,995

David G. Kabbes	MIP		—	$	0	$	287,625	$	575,250
	SA		2/16/2022								1,079		2,157		4,206							$	230,691
	SAR		2/16/2022																10,087	$	111.26	$	360,005

Arthur W. Mergner	MIP		—	$	0	$	358,125	$	716,250
	SA		2/16/2022								1,214		2,427		4,733							$	259,568
	SAR		2/16/2022																11,348	$	111.26	$	405,010

Sean T. Moriarty	MIP		—	$	0	$	328,125	$	656,250
	SA		2/16/2022								1,079		2,157		4,206							$	230,691
	SAR		2/16/2022																10,087	$	111.26	$	360,005

SEC Form DEF 14A filed by Stepan Company